- Set to Provide Real-time Monitoring Service for Tracking Cargo
Location and Strict Temperature Control -
TOKYO, June 25, 2024 /PRNewswire/ -- NIPPON EXPRESS
HOLDINGS, INC. has signed a strategic partnership agreement with
Iceland-based Controlant, Inc., a
leading provider of real-time monitoring devices for
pharmaceuticals.
Controlant's logo:
https://kyodonewsprwire.jp/img/202406202471-O1-sXfsB050
NX's logo:
https://kyodonewsprwire.jp/img/202406202471-O3-jlufE0EU
Image:
https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202406202471/_prw_PI2fl_jHGSHe9r.png
Headquartered in Iceland,
Controlant, a leading provider of real-time monitoring solutions
for tracking temperature and location information during transport,
enables transportation intervention and automated product release
in the highly regulated pharmaceutical industry. The company's
advanced technology and high-quality services, including platforms
compliant with FDA 21 CFR Part 11 (*1) and GxP (*2) -validated IoT
loggers, have been adopted by global pharmaceutical companies and
logistics service providers around the world.
The Nippon Express (hereinafter "NX") Group has positioned the
healthcare industry as a priority industry in its NX Group Business
Plan 2028 - Dynamic Growth 2.0 "Accelerating Sustainable Growth."
The Group has acquired Good Distribution Practices (GDP) (*3) and
CEIV Pharma certification (*4) at 34 business locations in 24
countries/regions worldwide, and is working to build quality
management systems and infrastructure.
Through this strategic partnership agreement with Controlant,
the NX Group will be able to provide transportation services with
end-to-end monitoring of cargo status, especially for
pharmaceutical and healthcare products requiring strict temperature
control. Customers will also be able to optimize their supply chain
processes by linking the NX Group's e-NX Visibility tracking system
with Controlant's real-time data logger.
Image of e-NX Visibility viewing screen:
https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202406202471/_prw_PI4fl_YxaU40DO.png
The NX Group aims to contribute to the health of people around
the world by supporting its customers in the global pharmaceutical
and healthcare industry from a logistics perspective through the
establishment of a reliable and secure global pharmaceutical
logistics platform.
Notes:
(*1) FDA 21 CFR Part 11: A regulation established by the
U.S. Food and Drug Administration (FDA) defining the criteria under
which electronic data and electronic signatures are considered
trustworthy, reliable, and equivalent to paper records, compliance
with which is required when applying for marketing authorization of
drugs and food products.
(*2) GxP: Abbreviation for "Good Practice" quality guidelines
and regulations designed to ensure the safety and traceability of
products throughout the R&D, manufacturing, management,
storage, and distribution stages, where the "x" stands for various
fields, including the pharmaceutical industry.
(*3) GDP (GOOD DISTRIBUTION PRACTICE): Good Distribution
Practices for Pharmaceuticals.
(*4) CEIV Pharma: Abbreviation for the Center of Excellence for
Independent Validators in Pharmaceutical Logistics, a quality
certification program established by the International Air
Transport Association (IATA) to cover the air transport of
pharmaceutical products that sets out high standards encompassing
the differing Good Distribution Practice (GDP) guidelines of
countries around the world for the storage and transport of
pharmaceuticals.
About NX Group:
https://kyodonewsprwire.jp/attach/202406202471-O1-6kbYwfwA.pdf
About Controlant:
https://kyodonewsprwire.jp/attach/202406202471-O2-SwNINTXp.pdf
View original
content:https://www.prnewswire.co.uk/news-releases/nx-group-signs-strategic-partnership-agreement-with-controlant-of-iceland-302181194.html